Stock Market News3 days Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch
Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash overhang.
X3 hours Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune
X12 hours Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks
X12 hours Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks
X15 hours Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha
X18 hours The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks
X18 hours The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks
X1 day Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks
X1 day Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks
X1 day Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks
X2 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance
X2 days Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha
X3 days 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company
X3 days Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance
X3 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance
X3 days Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance
X3 days Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance
X4 days Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance
X4 days NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance
X4 days 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance
X4 days Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com
X4 days SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks
X4 days Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com
X4 days Pfizer: One Of The Next Big AI Winners Seeking Alpha
X1 week Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks
X1 week Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks
X1 week Pfizer: Why I’m Staying On The Sidelines Seeking Alpha
X1 week Better Income Stock: Pfizer or Altria Group? Yahoo Finance
X2 weeks Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha
X2 weeks Should Value Investors Buy Pfizer (PFE) Stock? Zacks
X2 weeks Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks
X2 weeks Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha
X2 weeks Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks
X2 weeks Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance
X2 weeks Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks
X2 weeks Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha
X2 weeks Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha
X2 weeks Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks
X2 weeks Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily
X2 weeks Final Trade: GOOG, SAIA, X, PFE YouTube
X2 weeks Pfizer climbs 4% on 2025 outlook YouTube
X2 weeks Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance
X2 weeks Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC
X2 weeks Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha
X2 weeks Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube
X2 weeks Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com
X2 weeks Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily
X3 weeks Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC
X3 weeks Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal
X3 weeks AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily
X3 weeks Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.